Company intelligence / Profile preview

National Fragile X Foundation

Washington, District of Columbia, United States
Ownership
Private
Employees
~15
Development stage
Other
01

Overview

The National Fragile X Foundation (NFXF) is a prominent non-profit organization dedicated to supporting individuals living with Fragile X-associated disorders and their families. Founded in 1984, the foundation focuses on three core pillars: community support, government advocacy, and the advancement of scientific research. NFXF spearheads the Fragile X Clinical & Research Consortium (FXCRC), which coordinates a network of specialized clinics to standardize and improve clinical care across the United States. By funding innovative research and facilitating clinical trial recruitment, the foundation plays a vital role in accelerating the development of new therapeutic modalities, including gene therapies and small molecule interventions. It serves as a critical bridge between the patient community, academic researchers, and the pharmaceutical industry to drive progress toward effective treatments and a eventual cure.

Therapeutic areas
NeurologyWomen's Health
Modalities
Small moleculeGene therapyAntisense oligonucleotideNon-pharmacological therapy
Industry
Academic Hospital/University/Research
02

Partnerships

Fragile X Clinical & Research Consortium (FXCRC)FRAXA Research FoundationNational Institutes of Health (NIH)Centers for Disease Control and Prevention (CDC)

Beyond the preview

Go deeper on National Fragile X Foundation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on National Fragile X Foundation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call